New research project on CRISPR technologies in national funding initiative

Our research group has received funding of 117,000 EUR for our research project titled "Pioneering molecular surgery with CRISPR technologies for personalized lung cancer therapy."

As part of the newly established national funding initiative "National Funding of Translational Projects in the Field of Gene and Cell Therapy and Associated Diagnostics," Shady Sayed from our lab and Annina Meerz from the NCT will aim to develop groundbreaking molecular surgical techniques using CRISPR technologies to enable personalized therapy approaches for lung cancer patients.

The kick-off meeting took place in April in Berlin and provided all participants with a framework for the first exchange of ideas and to strengthen collaboration.

Background: The Federal Ministry of Education and Research (BMBF) is funding projects at the Berlin Institute of Health at Charité (BIH) for the further development of gene- and cell-based therapies and corresponding diagnostics. The goal of this initiative is to accelerate the development of these therapies into market-ready products and to promote collaboration between academic, non-academic, and industrial partners.

For more details, please visit the BIH webiste.